Submit Your Paper Editorial Board Publication Charge Open Access and Copyright Indexing Info Archive

Indexing Information

J Ren Endocrinol. 2025;11: e25184 | Published on: 2025 Feb 22. doi: 10.34172/jre.2025.25184

Mini-Review

Febuxostat versus allopurinol for renoprotection; a mini-review on recent concepts

Hossein Mardanparvar ^1,2 *

Cited by CrossRef: 0

1- Shi W, Huang X, Zhao X, jiang J, Fan G, Lou Y. Safety profiles of two XOD and two URAT1 inhibitors in hyperuricemic patients: a real-world pharmacovigilance analysis based on the FAERS and JADER databases. Naunyn-Schmiedeberg's Arch Pharmacol. 2026; [Crossref]